286 C. Christodoulou et al PSYCHIATRIKI 21 (4), 201039. Tedman B, Young C, Williams I. Assessment of depressionin patients with motor neuron disease and other neurologicaldisabling illness. J Neurologic Sci 1997, 152(Suppl1):75–7940. Clarke D, Smith G, Herrman H. A comparative study ofscreening instruments for mental disorders in general hospitalpatients. Int J Psychiatry Med 1993, 23:323–33741. Silverstone P. Poor efficacy of the Hospital Anxiety andDepression Scale in the diagnosis of major depressive inboth medical and psychiatric patients. J Psychosom Res1994, 38:441–45042. Kugaya A, Akechi T, Okuyama H, Uchitomi Y. Screening forpsychological distress in Japanese cancer patients. JapanJ Clin Ongol 1998, 28:333–33843. Trerluin B, Brouwers E, van Marwijk H, Verhaak P, vander Horst H. Detecting depressive and anxiety disorders indistressed patients in primary care, comparative diagnosticaccuracy of the four-dimensional symptom questionnaire(4DSQ) and the Hospital Anxiety and Depression Scale(HADS). BMC Fam Pract 2009, 10:5844. Demyttenaere K, Verhaeghen A, Dantchev N, Grassi L,Montejo A, Perahia D et al. “Caseness” for depressionand anxiety in depressed outpatient population: symptomaticoutcome as function of baseline diagnostic categories.Primary Care Companion. J Clin Psychiatry 2009,11:307–315Corresponding author: Chr. Christodoulou, MD, Ast. Professor ofPsychiatry, 2nd Department of Psychiatry, Medical School, Universityof Athens, "Attikon" General Hospital, 1 Rimini street, GR-124 62Athens, GreeceTel.: 210-58 32 426, Fax: 210-53 26 453e-mail: christo.christodoulou@gmail.com
PSYCHIATRIKI 21 (4), 2010 287Research articleΕρευνητική εργασίαEvaluation of cognitive-analytic therapy(CAT) outcomein patients with panic disorderP. Tzouramanis, 1 A. Adamopoulou, 1 V. Bozikas, 2 M. Voikli 1C. Zagora, 1 M. Lombtzianidou, 1 E. Mamouzelos, 1 G. Garyfallos 31 Community Mental Health Center of Northwestern District, Thessaloniki, 2 1st Department of Psychiatry, Aristotle Universityof Thessaloniki, 3 2nd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, GreecePsychiatriki 2010, 21:287–293Two categories of treatment have been shown to be effective in treating panic disorder with orwithout agoraphobia. One is pharmacotherapy using antidepressants and benzodiazepinesand the other is psychotherapy. The present study aims at the assessment of the outcome ofCognitive-Analytic Therapy (CAT), a type of brief psychotherapy, in a sample of 128 psychiatricoutpatients with DSM-IV diagnosis of panic disorder, who attended the Mental Health Centerof Northwestern District of Thessaloniki. For this purpose, validated instruments for the evaluation,such as the Minnesota Multiphasic Personality Inventory (MMPI), the Beck Depression Inventory(BDI), the State-Trait Anxiety Inventory (STAI) and the Post-therapy Questionnaire (PtQ), were used.The patients were evaluated in two follow ups, 2 months and 1 year after therapy termination. Theresults showed that on the 2 month follow up 78 patients showed a statistically significant improvementin comparison to the intake time, in all but two (Mf, Ma) clinical scales of the MMPI, on theirsum and on some research scales of the MMPI, on the BDI and on the STAI scores. On the 1-yearfollow-up, according to the results of the MMPI, BDI, STAI and PtQ, the patients maintained theachieved improvement. The above results indicate that CAT is an effective brief psychotherapeuticapproach for patients with panic disorder.Key words: panic disorder, cognitive-analytic therapy
- Page 5: PSYCHIATRIKIQuarterly journal publi
- Page 9 and 10: PSYCHIATRIKI 21 (4), 2010 277Άρθ
- Page 11 and 12: PSYCHIATRIKI 21 (4), 2010 279Resear
- Page 13 and 14: PSYCHIATRIKI 21 (4), 2010 HOSPITAL
- Page 15 and 16: PSYCHIATRIKI 21 (4), 2010 HOSPITAL
- Page 17: PSYCHIATRIKI 21 (4), 2010 HOSPITAL
- Page 22 and 23: 290 P. TZOURAMANIS et al PSYCHIATRI
- Page 24 and 25: 292 P. TZOURAMANIS et al PSYCHIATRI
- Page 26 and 27: 294 PSYCHIATRIKI 21 (4), 2010Resear
- Page 28 and 29: 296 M. VLASSOPOULOS et al PSYCHIATR
- Page 30 and 31: 298 M. VLASSOPOULOS et al PSYCHIATR
- Page 32 and 33: 300 M. VLASSOPOULOS et al PSYCHIATR
- Page 34 and 35: 302 M. VLASSOPOULOS et al PSYCHIATR
- Page 36 and 37: 304 PSYCHIATRIKI 21 (4), 2010Resear
- Page 38 and 39: 306 H. LAZARATOU et al PSYCHIATRIKI
- Page 40 and 41: 308 H. LAZARATOU et al PSYCHIATRIKI
- Page 42 and 43: 310 H. LAZARATOU et al PSYCHIATRIKI
- Page 44 and 45: 312 H. LAZARATOU et al PSYCHIATRIKI
- Page 46 and 47: 314 H. LAZARATOU et al PSYCHIATRIKI
- Page 48 and 49: 316 C. Kouimtsidis PSYCHIATRIKI 21
- Page 50 and 51: 318 C. Kouimtsidis PSYCHIATRIKI 21
- Page 52 and 53: 320 C. Kouimtsidis PSYCHIATRIKI 21
- Page 54 and 55: 322 C. Kouimtsidis PSYCHIATRIKI 21
- Page 56 and 57: 324 PSYCHIATRIKI 21 (4), 2010Specia
- Page 58 and 59: 326 B.J. HAVAKI-KONTAXAKI et al PSY
- Page 60 and 61: 328 B.J. HAVAKI-KONTAXAKI et al PSY
- Page 62 and 63: 330 B.J. HAVAKI-KONTAXAKI et al PSY
- Page 64 and 65: 332 PSYCHIATRIKI 21 (4), 2010Genera
- Page 66 and 67: 334 C.I. Istokoglou et al PSYCHIATR
- Page 68 and 69:
336 C.I. Istokoglou et al PSYCHIATR
- Page 70 and 71:
338 C.I. Istokoglou et al PSYCHIATR
- Page 72 and 73:
340 PSYCHIATRIKI 21 (4), 2010• 10
- Page 74 and 75:
SUBMISSIONPapers either in English
- Page 76 and 77:
ΥΠΟΒΟΛΗ ΕΡΓΑΣΙΩΝΟι
- Page 78:
ΣΥΝΟΔΕΥΤΙΚΟ ΕΝΤΥΠΟ